Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,279,367
-
Share change
-
-44,685
-
Total reported value
-
$82,042,365
-
Price per share
-
$64.10
-
Number of holders
-
95
-
Value change
-
-$2,862,018
-
Number of buys
-
18
-
Number of sells
-
41
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2025
As of 30 Jun 2025,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,279,367 shares.
The largest 10 holders included
Gerber Kawasaki Wealth & Investment Management, MORGAN STANLEY, LPL Financial LLC, UBS Group AG, Royal Bank of Canada, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC, and YHB Investment Advisors, Inc..
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.